Nivolumab
Brand name: Opdivo
Rank #462 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$16.0M
Total Cost
1,275
Total Claims
$16.0M
Total Cost
51
Prescribers
$13K
Cost per Claim
63
Beneficiaries
1,280
30-Day Fills
$314K
Avg Cost/Provider
25
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$16.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $16.0M total
🔎 Data Overview
At $12,574 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $314,339 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $254,465 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Nivolumab
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Swetha Yadav | Hematology-Oncology | Spring, TX | 110 | $1.5M |
| 2 | Ari Baron | Hematology-Oncology | San Francisco, CA | 100 | $1.2M |
| 3 | Songchuan Guo | Hematology-Oncology | Brooklyn, NY | 82 | $1.1M |
| 4 | Asit Choksi | Medical Oncology | The Woodlands, TX | 63 | $794K |
| 5 | Azriel Hirschfeld | Hematology-Oncology | Brooklyn, NY | 38 | $606K |
| 6 | Youram Nassir | Hematology | Los Angeles, CA | 39 | $522K |
| 7 | David Ellent | Hematology-Oncology | Kingwood, TX | 36 | $513K |
| 8 | Antoine Chahine | Medical Oncology | Canfield, OH | 62 | $510K |
| 9 | John Graham | Hematology-Oncology | Canfield, OH | 63 | $502K |
| 10 | Norland Ng | Hematology-Oncology | New York, NY | 28 | $443K |
| 11 | Vinicio Hernandez | Hematology-Oncology | Orlando, FL | 27 | $363K |
| 12 | Minal Shah | Hematology-Oncology | California, MD | 24 | $354K |
| 13 | Angela Lu | Nurse Practitioner | Des Moines, IA | 28 | $323K |
| 14 | Giuseppe Condemi | Hematology-Oncology | New York, NY | 21 | $308K |
| 15 | Brian Leberthon | Hematology-Oncology | West Covina, CA | 16 | $294K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 459 | Telmisartan (Telmisartan) | $16.4M | 334,601 |
| 460 | Letermovir (Prevymis) | $16.1M | 2,144 |
| 461 | Fluphenazine Hcl (Fluphenazine Hcl) | $16.0M | 73,051 |
| 462 | Nivolumab (Opdivo) | $16.0M | 1,275 |
| 463 | Leflunomide (Leflunomide) | $16.0M | 205,765 |
| 464 | Hydrocortisone (Hydrocortisone) | $15.9M | 762,398 |
| 465 | Digoxin (Digoxin) | $15.9M | 548,410 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology